News
C4 Therapeutics Presents New Preclinical Data For CFT1946 Highlighting Superior Activity As A Single Agent To Clinically Approved BRAF Inhibitor Standard Of Care Combinations At The American Association For Cancer Research Annual Meeting 2024
8 Apr 24
Biotech, News, General
C4 Therapeutics To Present New Preclinical Data On Highly Selective Orally Bioavailable BiDAC Degraders At The American Association For Cancer Research Annual Meeting 2024
5 Mar 24
Biotech, News, General
Breaking Down C4 Therapeutics: 4 Analysts Share Their Views
26 Feb 24
Analyst Ratings
Morgan Stanley Maintains Equal-Weight on C4 Therapeutics, Raises Price Target to $8
26 Feb 24
News, Price Target, Analyst Ratings
C4 Therapeutics FY EPS $(2.67) Down From $(2.62) YoY, Sales $20.76M Down From $31.10M YoY
22 Feb 24
Earnings, News
Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
20 Feb 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Analyst Expectations For C4 Therapeutics's Future
29 Jan 24
Analyst Ratings
JP Morgan Upgrades C4 Therapeutics to Neutral, Announces $6 Price Target
29 Jan 24
News, Upgrades, Price Target, Analyst Ratings
Press releases
Thinking about buying stock in C4 Therapeutics, Safety Shot, Intuitive Machines, Cardiol Therapeutics, or Iovance Biotherapeutics?
21 Feb 24
Small Cap, Opinion, Press Releases
Thinking about buying stock in Alibaba Group, Akebia Therapeutics, Plug Power, AMC Entertainment, or C4 Therapeutics?
1 Feb 24
Opinion, Press Releases